Eversept Partners, LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$4,421,422
-24.5%
1,681,149
+1.4%
0.37%
-23.5%
Q2 2023$5,853,428
-2.3%
1,658,195
-14.4%
0.49%
+17.0%
Q1 2023$5,988,692
-6.1%
1,938,088
+28.5%
0.42%
-25.1%
Q4 2022$6,377,414
+78.7%
1,507,663
+0.1%
0.56%
+80.6%
Q3 2022$3,568,521
-12.7%
1,505,705
+4.9%
0.31%
+6.2%
Q2 2022$4,089,969
-0.3%
1,435,077
+0.7%
0.29%
-7.6%
Q1 2022$4,102,992
+20.7%
1,424,650
+27.4%
0.32%
+45.2%
Q4 2021$3,398,410
+21.8%
1,117,898
+180.9%
0.22%
+11.9%
Q3 2021$2,789,559
+467.4%
397,940
+583.1%
0.19%
+59.0%
Q1 2020$491,638
-42.9%
58,251
+37.7%
0.12%
-73.8%
Q4 2018$860,825
-13.4%
42,301
+95.2%
0.47%
+6.9%
Q3 2018$993,615
-29.8%
21,671
-9.4%
0.44%
-32.6%
Q2 2018$1,415,105
-9.3%
23,924
+4.4%
0.65%
-10.8%
Q1 2018$1,559,978
-71.1%
22,924
-58.1%
0.72%
-76.7%
Q4 2017$5,402,05454,6493.11%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders